Loading
Latest filing published 31 Oct 2019 for RAMM Pharma Corp..
No signal scores available.
Matthew Bajurny discloses dealings in RAMM Pharma Corp. to SEDI. In total, 2 filings cover trades dated from 18 October 2019 to 28 October 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 31 October 2019, reports a transaction in RAMM Pharma Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations